0001209191-23-050476.txt : 20230925
0001209191-23-050476.hdr.sgml : 20230925
20230925162140
ACCESSION NUMBER: 0001209191-23-050476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230921
FILED AS OF DATE: 20230925
DATE AS OF CHANGE: 20230925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rock Edwin
CENTRAL INDEX KEY: 0001945417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36177
FILM NUMBER: 231276086
MAIL ADDRESS:
STREET 1: 9708 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLYCOMIMETICS INC
CENTRAL INDEX KEY: 0001253689
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9708 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-243-1201
MAIL ADDRESS:
STREET 1: 9708 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-21
0
0001253689
GLYCOMIMETICS INC
GLYC
0001945417
Rock Edwin
C/O GLYCOMIMETICS, INC
9708 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-09-21
4
P
0
35000
1.38
A
345000
D
Common Stock
2023-09-22
4
P
0
30403
1.38
A
375403
D
The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.35 to $1.40 per share, with a weighted average purchase price of $1.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.37 to $1.40 per share, with a weighted average purchase price of $1.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
/s/ Brian F. Leaf, attorney-in-fact
2023-09-25